ACTIVE PHARMACEUTICAL INGREDIENTSPRODUCT CATALOGUE

Items covered by valid patents are not offered or supplied for commercial sale.

The patent position should be verified by the buyer.

***Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).***

Cardiovascular system

Cardiovascular system

Cardiovascular system

Antineoplastic and immunomodulating agents

Blood and blood forming organs

Respiratory system

Nervous system

Dermatologicals

Sensory organs

Nervous system

Ophthalmology

Respiratory system

Antineoplastic and immunomodulating agents

Azelnidipine

Azilsartan (Base)

Azilsartan Medoxomil Potassium

Baricitinib

Betrixaban

Bilastine

Brivaracetam

Crisaborole

Li�tegrast

Mirogabalin

Netarsudil

Tezacaftor

Tofacitinib (Base)

APIs - Under Development Therapeutic Area (Broader Terms)

April 2018

Committed to

internationally accepted

standards of quality,

purity, ef�cacy and safety

across all our operations

Been relentless in

stepping up our quality

systems to ensure that

our products, processes

and infrastructure

measures up to

international

expectations

Manufacturing facilities

across the globe are

approved by regulatory

bodies such as the

US-FDA, UK-MHRA,

WHO-GMP, Canadian

TPD, South African MCC

and ANVISA of Brazil

Regular training

programmes to

guarantee that

employees implement

higher standards by

the day

Work ceaselessly, not only

to meet the stringent

regulations but also to set

new benchmarks

Ensuring high-quality and compliance

across all operations

Items covered by valid patents are not offered or supplied for commercial sale.

The patent position should be verified by the buyer.

***Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).***

ACTIVE PHARMACEUTICAL INGREDIENTSPRODUCT CATALOGUE

A

B

C

D

E

Dermatologicals

Alimentary tract and metabolism

Cardiovascular system

Blood and blood forming organs

Antineoplastic and immunomodulating agents

Alimentary tract and metabolism

Respiratory system

Antiparasitic products, insecticides and repellents

Dermatologicals

Cardiovascular system

Cardiovascular system

Nervous system

Dermatologicals

Alimentary tract and metabolism

Cardiovascular system

Blood and blood forming organs

Antiinfectives for systemic use

Blood and blood forming organs

Alimentary tract and metabolism

Genito urinary system and sex hormones

Various

Alimentary tract and metabolism

Respiratory system

Nervous system

Cardiovascular system

Cardiovascular system

Dermatologicals

Alimentary tract and metabolism

Alimentary tract and metabolism

Adapalene

Alogliptin

Amiodarone

Apixaban

Apremilast

Aprepitant

Arformoterol

Atovaquone

Azelaic Acid

Bisoprolol Fumarate

Bosentan

Bupropion HCl

Butena�ne HCl

Canagli�ozin

Cilazapril

Cilostazol

Colistimethate Na

Dabigatran

Dapagli�ozin

Darifenacin

Deferasirox

Deoxycholic Acid

Desloratadine

Dimethyl Fumarate

Dipyridamole

Dronedarone

E�naconazole

Esomeprazole Mg (Dihydrate)

Esomeprazole Mg (Trihydrate)

APIs - Validated Therapeutic Area Regulatory Filings

March 2018

Antiinfectives for systemic useDaclatasvir Dihydrochloride (Novel)

M

N

O

F

G

I

L

Items covered by valid patents are not offered or supplied for commercial sale.

The patent position should be verified by the buyer.

***Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).***

ACTIVE PHARMACEUTICAL INGREDIENTSPRODUCT CATALOGUE

Nervous system

Antineoplastic and immunomodulating agents

Cardiovascular system

Nervous system

Antiinfectives for systemic use

Alimentary tract and metabolism

Nervous system

Antiinfectives for systemic use

Alimentary tract and metabolism

Dermatologicals

Respiratory system

Nervous system

Cardiovascular system

Respiratory system

Alimentary tract and metabolism

Eszopiclone

Etoricoxib

Ezetimibe

Fingolimod

Fluconazole

Fosaprepitant

Frovatriptan

Garenoxacin

Glimepiride

Imiquimod

Ivacaftor

Lacosamide

Lercanidipine

Levocetirizine

Linagliptin

APIs - Validated Therapeutic Area Regulatory Filings

March 2018

Alimentary tract and metabolismEsomeprazole Sodium

Nervous system

Cardiovascular system

Respiratory system

Nervous system

Dermatologicals

Nervous system

Nervous system

Genito urinary system and sex hormones

Cardiovascular system

Pain

Respiratory system

Sensory organs

Cardiovascular system

Lithium Carbonate

Lomitapide

Loratadine

Lornoxicam

Luliconazole

Lurasidone

Milnacipran

Mirabegron

Moexipril

Naproxen Sodium

Nintedanib

Olopatadine

Olmesartan

Alimentary tract and metabolismOmeprazole

P

R

S

T

Items covered by valid patents are not offered or supplied for commercial sale.

The patent position should be verified by the buyer.

***Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).***

ACTIVE PHARMACEUTICAL INGREDIENTSPRODUCT CATALOGUE

Genito urinary system and sex hormones

Nervous system

Cardiovascular system

Cardiovascular system

Respiratory system

Blood and blood forming organs

Cardiovascular system

Antiparasitic products, insecticides and repellents

Cardiovascular system

Nervous system

Nervous system

Nervous system

Blood and blood forming organs

Nervous system

Respiratory system

Nervous system

Cardiovascular system

Nervous system

Alimentary tract and metabolism

Dermatologicals

Alimentary tract and metabolism

Genito urinary system and sex hormones

Cardiovascular system

Dermatologicals

Antiinfectives for systemic use

Cardiovascular system

Alimentary tract and metabolism

Nervous system

Blood and blood forming organs

Ospemifene

Oxcarbazepine

Perindopril Erbumine

Perindopril Arginine

Pirfenidone

Prasugrel

Pravastatin

Proguanil

Ranolazine

Rasagiline Mesylate

Rasagiline Tartarate

Riluzole

Rivaroxaban

Rizatriptan

Ro�umilast

Ropinirole

Rosuvastatin Calcium

Ru�namide

Saxagliptin

Sertaconazole Nitrate

Sitagliptin

Solifenacin Succinate

Tadala�l

Tavaborole

Terbina�ne HCl

Telmisartan

Teneligliptin

Teri�unomide

Ticagrelor

APIs - Validated Therapeutic Area Regulatory Filings

March 2018

Antineoplastic and immunomodulating agentsTofacitinib Citrate

U

V

Z

Items covered by valid patents are not offered or supplied for commercial sale.

The patent position should be verified by the buyer.

***Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).***

ACTIVE PHARMACEUTICAL INGREDIENTSPRODUCT CATALOGUE

Nervous system

Cardiovascular system

Genito urinary system and sex hormones

Alimentary tract and metabolism

Nervous system

Alimentary tract and metabolism

Antiinfectives for systemic use

Nervous system

Nervous system

Nervous system

Topiramate

Trandolapril

Trospium

Ursodiol

Vilazodone

Vildagliptin

Voriconazole

Zolmitriptan

Zolpidem

Zonisamide

APIs - Validated Regulatory FilingsTherapeutic Area

March 2018